The aforementioned pathomechanisms prompt the use of vasodilator-based polytherapy (angiotensin-converting enzyme inhibitors, calcium blockers) in combination with diuretics for the treatment of hypertension in this patient group. The gene discussed is ACE; the disease is Hypertension.